- Home
- UNCY vs PRT Comparison
UNCY vs PRT Comparison
Compare UNCY & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- PRT
- Stock Information
- Founded
- UNCY 2016
- PRT 2017
- Country
- UNCY United States
- PRT United States
- Employees
- UNCY N/A
- PRT N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- PRT Oil & Gas Production
- Sector
- UNCY Health Care
- PRT Energy
- Exchange
- UNCY Nasdaq
- PRT Nasdaq
- Market Cap
- UNCY 56.4M
- PRT 48.2M
- IPO Year
- UNCY 2021
- PRT N/A
- Fundamental
- Price
- UNCY $4.70
- PRT $3.98
- Analyst Decision
- UNCY Strong Buy
- PRT
- Analyst Count
- UNCY 4
- PRT 0
- Target Price
- UNCY $63.75
- PRT N/A
- AVG Volume (30 Days)
- UNCY 384.1K
- PRT 28.4K
- Earning Date
- UNCY 08-14-2025
- PRT 08-13-2025
- Dividend Yield
- UNCY N/A
- PRT 10.94%
- EPS Growth
- UNCY N/A
- PRT 1.16
- EPS
- UNCY N/A
- PRT 0.44
- Revenue
- UNCY N/A
- PRT $6,314,770.00
- Revenue This Year
- UNCY N/A
- PRT N/A
- Revenue Next Year
- UNCY $1,178.98
- PRT N/A
- P/E Ratio
- UNCY N/A
- PRT $9.04
- Revenue Growth
- UNCY N/A
- PRT 1.82
- 52 Week Low
- UNCY $2.75
- PRT $3.26
- 52 Week High
- UNCY $11.00
- PRT $4.63
- Technical
- Relative Strength Index (RSI)
- UNCY 52.02
- PRT 45.31
- Support Level
- UNCY $3.97
- PRT $3.95
- Resistance Level
- UNCY $4.43
- PRT $4.05
- Average True Range (ATR)
- UNCY 0.25
- PRT 0.07
- MACD
- UNCY 0.10
- PRT -0.01
- Stochastic Oscillator
- UNCY 73.00
- PRT 27.27
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.